Skip to main content

CL7 1.5 mg Pill: yellow , capsule/oblong, 18mm

The pill with imprint CL7 1.5 mg (Yellow, Capsule/Oblong1) has been identified as Rivastigmine Tartrate 1.5 mg and is used for Parkinson's Disease, and Alzheimer's Disease. It belongs to the drug class cholinesterase inhibitors and is not a controlled substance.

Images for CL7 1.5 mg

Rivastigmine tartrate 1.5 mg CL7 1.5 mg
Rivastigmine tartrate 1.5 mg CL7 1.5 mg

Rivastigmine Tartrate

Imprint
CL7 1.5 mg
Strength
1.5 mg
Color
Yellow
Size
18.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Cholinesterase inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Macleods Pharmaceuticals Limited
National Drug Code (NDC)
33342-0089
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, silicon dioxide, gelatin, titanium dioxide, sodium lauryl sulfate, ferric oxide red, ferric oxide yellow, hypromelloses

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.